Ursprung des Netzwerks ersten Grades von James Moodie Rae
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada.
6
| Extinct | Biotechnology | 6 |
| Extinct | Pharmaceuticals: Major | 6 | |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
4
| Subsidiary | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von James Moodie Rae
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Toxin Alert, Inc.
 Toxin Alert, Inc. Medical SpecialtiesHealth Technology Toxin Alert, Inc. is a biotechnology company engaged in protecting consumers from unsafe food. It is currently focused on U.S. patented Toxin Guard for food freshness and safety test, which will have its first commercial application in food packaging materials. The company was founded on September 15, 1998 and is headquartered in Toronto, Canada. | Medical Specialties | Chief Executive Officer | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
GLYCODesign, Inc.
 GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director of Finance/CFO | |
| E3 LITHIUM LIMITED | Chemicals: Specialty | Director/Board Member Director of Finance/CFO | |
| LIPOSCIENCE INC | Medical Specialties | Director/Board Member | |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Chief Operating Officer | |
| HELIX BIOPHARMA CORP. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Director/Board Member | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member | |
Millenium Biologix Corp.
 Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Biotechnology | Director/Board Member President | |
| RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | President Director/Board Member | |
Hapten Sciences, Inc.
 Hapten Sciences, Inc. Pharmaceuticals: MajorHealth Technology Hapten Sciences, Inc. is a biopharmaceutical company. It identifies and develops novel, early-stage products that contribute to the health and well being of people around the world. Its product include PDC-APB, a small molecule that acts like a vaccine to prevent the extremely painful itching and rash. The company was founded by Raymond Joseph Hage Jr. and is headquartered in Memphis, TN. | Pharmaceuticals: Major | Director/Board Member | |
Gliacure, Inc.
 Gliacure, Inc. BiotechnologyHealth Technology Gliacure, Inc. is engaged in the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets. The company was founded by Philip Haydon in 2011 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
| Drexel University | College/University | Graduate Degree | |
GSK Products, Inc.
 GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Wholesale Distributors | Sales & Marketing | |
| McGill University | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
| York University | College/University | Masters Business Admin Graduate Degree | |
Apotex, Inc.
 Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal President Chief Tech/Sci/R&D Officer | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
| Concordia University | College/University | Undergraduate Degree Undergraduate Degree | |
| Indiana University | College/University | Masters Business Admin | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Manitoba | College/University | Undergraduate Degree Undergraduate Degree | |
| INSULET CORPORATION | Medical Specialties | Director/Board Member | |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Chairman | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
| Ontario Mental Health Research Foundation | Chairman | ||
| Licensing Executives Society | Director/Board Member | ||
| GLS Business Development, Inc. | Corporate Officer/Principal | ||
Humber River Health
 Humber River Health Hospital/Nursing ManagementHealth Services Humber River Health is a community hospital that values accountability and transparency in their healthcare services. The private company is based in Toronto, Canada, and has subsidiaries in Canada. The Canadian company believes in keeping their patients informed about their operations and services. | Hospital/Nursing Management | Chairman Director/Board Member | |
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology DeNovaMed, Inc. develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs. It focuses in the areas of Gram-positive infections, methicillin-resistant Staph and vancomycin-resistant Enterococcus pose a threat to patients in hospitals and community health facilities by producing skin, wound and systemic infections. The firm also has an ongoing discovery program for Gram-negative adjuvants, which can improve the efficacy of older antibacterial. The company was founded by Donald F. Weaver, Christopher R. McMaster and David Byers in 2006 and is headquartered in Halifax, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| Richard Ivey School of Business | College/University | Masters Business Admin | |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Director/Board Member | |
| Biscardia, Inc. | Director/Board Member | ||
| APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
NovaVive, Inc.
 NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada. | Biotechnology | Director/Board Member | |
| Qing Bile Therapeutics, Inc. | Director/Board Member |
Statistik
International
| Kanada | 25 |
| Vereinigte Staaten | 23 |
| Irland | 2 |
| Vereinigtes Königreich | 2 |
| China | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Process Industries | 2 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 186 |
| Corporate Officer/Principal | 63 |
| Chairman | 49 |
| Independent Dir/Board Member | 42 |
| President | 31 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Jeremy Curnock-Cook | 60 |
| Joseph Zakrzewski | 30 |
| Gary Littlejohn | 16 |
| Guillermo Marmol | 16 |
| Graham Strachan | 15 |
| Neil Warma | 15 |
| Jacob M. Kay | 14 |
| Warren Whitehead | 14 |
| Perry B. Molinoff | 12 |
| Scott Robert Samuel | 12 |
| Robert Gundel | 10 |
| R. Craig Baxter | 9 |
| John M. Langstaff | 8 |
| Mathieu Boudreau | 7 |
- Börse
- Insiders
- James Moodie Rae
- Unternehmensverbindungen
